Warner pharmaceutical: drugs pass the consistency evaluation of quality and efficacy of generic drugs
Warner pharmaceutical announced that the company has received the notice of approval for supplementary drug application for mycophenolate mofetil capsules approved and issued by the State Drug Administration. The drug mycophenolate mofetil capsule was evaluated by the consistency of quality and efficacy of generic drugs. The application of mycophenolate mofetil capsule together with corticosteroids, cyclosporine or tacrolimus is suitable for the treatment of patients receiving allogeneic kidney transplantation and liver transplantation, the prevention of organ rejection, and the induction and maintenance treatment of patients with type III-V adult lupus nephritis.
This text is a result of machine translation.
Related companies：
Briefing May 11, 2022 01:15 PM
· Technology
Photovoltaic sector continues to be active
Briefing May 10, 2022 06:30 PM
· Technology
Boschke: the consortium pre won the 168 million yuan EPC project
In-depth
Briefing Apr 28, 2022 08:55 AM
CITIC Securities: the auction price of lithium concentrate rose sharply, and the lithium plate rebounded or advanced
May 02, 2022 07:50 PM
Apr 18, 2022 09:14 PM
Apr 18, 2022 06:30 PM
Apr 11, 2022 08:42 PM
Technology
CRM Services Provider Xuanwu Cloud is to be listed on the Hong Kong Main Board on July 8
Xuanwu Cloud, a Chinese intelligent CRM services provider that has made several attempts for an IPO, plans to get listed on the Hong Kong Main Board on July 8 and offer 34,390,500 shares with a price range from HKD 4.93 (USD 0.63) to HKD 6.91. Its CRM services mainly consist of CRMPaaS and CRMSaaS.
Updated 35 mins ago
In-depth
Technology
Successful Multinational Corporations in China Series: Qualcomm China
Since China's reform and opening-up, many multinational corporations and groups have achieved success in China. They have not only been successful in their fields, but some also benefitted from wise M&A moves or investments. To answer these questions EqualOcean launches its Successful Multinational Corporations in China and analyzes the critical points of investing in China for investors and people interested in such a topic.
Jun 25, 2022 02:02 PM
Briefing Mar 10, 2022 12:48 PM
· Consumer Staples
Half day net inflow of main funds into photovoltaic and lithium batteries, selling small metals, etc
See more
Read next
In-depth
Healthcare
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Updated 6 hours ago
In-depth
Technology
Successful Multinational Corporations in China Series: Qualcomm China
Jun 25, 2022 02:02 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.